SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Stocks Crossing The 13 Week Moving Average <$10.01 -- Ignore unavailable to you. Want to Upgrade?


To: James Strauss who wrote (1684)5/25/1998 9:58:00 PM
From: Instock  Read Replies (1) | Respond to of 13094
 
Wart, Your picks are looking better and better all the time!!! You are getting confirmation on your picks!!

Good Luck!!

instock



To: James Strauss who wrote (1684)5/25/1998 10:43:00 PM
From: Magnatizer  Read Replies (1) | Respond to of 13094
 
Thread

Robert Cohen just recommended AKLM on Bloomberg interview. Called for a target of $10

ht
david



To: James Strauss who wrote (1684)5/26/1998 10:18:00 AM
From: IsaacF1  Read Replies (1) | Respond to of 13094
 
James:

RECY, an important step in the growth process:

investor.msn.com

IsaacF1



To: James Strauss who wrote (1684)5/29/1998 3:08:00 PM
From: James Strauss  Read Replies (1) | Respond to of 13094
 
BJCT... Investing In A Concept...
~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~
Develops, manufactures and distributes a jet injection system capable of injecting medications through the skin without traditional needle puncture.
**********************************************************************
I'm tucking this one away... It's a story stock... You can't go by the fundamentals... You either have to believe in the story or not...

I think BJCT will revolutionize the immunization industry... It is also working on Glucose testing for Diabetics without the annoying and painful sticking of the skin with a needle...

There may come a time that some big announcement will shoot the stock up like ICOS or ENMD... While highly speculative, the rewards far outweigh the Risks...

quicken.com

quicken.com

Jim